Back to search
Acute Coronary Syndromes (ACS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Coronary Syndromes (ACS) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Coronary Syndromes (ACS) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
CG-0255 is a novel investigational prodrug of the active metabolite of Plavix®， but with different active metabolite conversion routes. This is a randomized, op…
The goal of this observational study is to evaluate whether artificial intelligence (AI) algorithms can predict or exclude acute coronary syndrome (ACS) in adul…
The purpose of this trial is to learn about the effects of inclisiran in people with serious heart conditions (acute coronary syndromes), when this treatment is…
This is a placebo-controlled, randomized, double-blind, parallel group, phase 3 multicenter study in subjects recently hospitalized for ACS and with the appropr…
This is a randomized, controlled study. ACS follow- up patients aged 18 to 80 years old with hemodynamic stability, who are 14 days to 1 year after PCI, are scr…
More than 25% of patients referred for diagnostic coronary angiography and percutaneous coronary intervention (PCI) due to acute coronary syndrome (ACS) suffer…
The aim is to compare the safety of using telemedicine and office visit follow-up in post-acute coronary syndrome patients
Even with standard treatments like statins, patients with coronary artery disease often face a residual risk of further heart events. This risk is largely drive…